Bristol-Myers Squibb Company (BMY)

Exchange
NYSE
Symbol
BMY
Sector
Life Sciences
Industry
Pharmaceutical Preparations
Description
Bristol Myers Squibb (BMS) is an American multinational pharmaceutical company, headquartered in New York City. Bristol Myers Squibb manufactures prescription pharmaceuticals and biologics in several therapeutic areas, including cancer, AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis and psychiatric disorders.
Country
USA

Stock price

At close: November 5, 2024

  • Open
    55.14
  • High
    56.28
  • Low
    54.72
  • Close
    55.95
  • Volume
    9,278,020

Financial ratios

Dec 31, 2023

Activity ratios
Inventory turnover
10.57
Receivables turnover
4.12
Payables turnover
8.63
Working capital turnover
4.73
Days of inventory on hand (DOH)
34.53
Days of sales outstanding (DSO)
88.57
Number of days of payables
42.27
Fixed asset turnover
6.77
Total asset turnover
0.47
 Liquidity ratios
Current ratio
1.43
Quick ratio
1.06
Cash ratio
0.57
Cash conversion cycle
80.83
 Solvency ratios
Debt-to-assets ratio
0.39
Debt-to-capital ratio
0.55
Debt-to-equity ratio
1.25
Financial leverage ratio
3.23
Interest coverage
8.23
 Profitability ratios
Gross profit margin
37.48%
Operating profit margin
-21.12%
Pretax margin
18.72%
Net profit margin
17.83%
Operating return on assets (Operating ROA)
-9.99%
Return on assets (ROA)
8.43%
Return on total capital
14.51%
Return on equity (ROE)
27.27%